Literature DB >> 8288881

The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity.

D Goldblatt1, L van Etten, F J van Milligen, R C Aalberse, M W Turner.   

Abstract

Solid phase assays for the measurement of functional antibody affinity are increasingly being used in both clinical and research settings. The majority of such assays employ a chemical reagent to disturb antibody binding but relatively little is known about the properties of such reagents and the basis of their effect on antigen-antibody binding. We have evaluated the diethylamine (DEA) ELISA procedure for the measurement of functional antibody affinity in two independent assays, one for functional human IgG subclass affinity to an organism, Moraxella catarrhalis, and the other for measuring functional affinity of mouse monoclonals specific for the cat allergen Fel d I. DEA was shown to increase the pH of the buffering solution and it was this rise in pH that affected antibody binding. Alkaline buffer and DEA were equally efficient in the inhibition of binding of both the human IgG subclasses and the two mouse monoclonal antibodies to the solid phase. In contrast, pH was shown to have no role in the chaotropic effect of the ion, thiocyanate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288881     DOI: 10.1016/0022-1759(93)90369-i

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  A differential cell capture assay for evaluating antibody interactions with cell surface targets.

Authors:  David J Sherman; Vania E Kenanova; Eric J Lepin; Katelyn E McCabe; Ken-Ichiro Kamei; Minori Ohashi; Shutao Wang; Hsian-Rong Tseng; Anna M Wu; Christian P Behrenbruch
Journal:  Anal Biochem       Date:  2010-02-21       Impact factor: 3.365

2.  Specific antigen/antibody interactions measured by force microscopy.

Authors:  U Dammer; M Hegner; D Anselmetti; P Wagner; M Dreier; W Huber; H J Güntherodt
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

3.  Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.

Authors:  C L Vermont; H H van Dijken; C J P van Limpt; R de Groot; L van Alphen; G P J M van Den Dobbelsteen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Correlation of molecular characteristics, isotype, and in vitro functional activity of human antipneumococcal monoclonal antibodies.

Authors:  H E Baxendale; D Goldblatt
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  Concomitant administration of Mycobacterium bovis BCG with the meningococcal C conjugate vaccine to neonatal mice enhances antibody response and protective efficacy.

Authors:  Siggeir F Brynjolfsson; Stefania P Bjarnarson; Elena Mori; Giuseppe Del Giudice; Ingileif Jonsdottir
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

6.  Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.

Authors:  Thorunn Asta Olafsdottir; Karen Lingnau; Eszter Nagy; Ingileif Jonsdottir
Journal:  Infect Immun       Date:  2011-10-24       Impact factor: 3.441

7.  Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs.

Authors:  Josefine Persson; Yuan Zhang; Thorunn A Olafsdottir; Karolina Thörn; Tina M Cairns; Frank Wegmann; Quentin J Sattentau; Roselyn J Eisenberg; Gary H Cohen; Ali M Harandi
Journal:  Front Immunol       Date:  2016-12-26       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.